REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPG.L Regulatory News (TPG)

  • There is currently no data for TPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - TP Group plc

31 Oct 2022 17:22

RNS Number : 8037E
Science Group PLC
31 October 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Science Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TP Group plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

28 October 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

1p Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

217,923,105

27.97

Nil

0

(2) Cash-settled derivatives:

 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

TOTAL:

217,923,105

27.97

Nil

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

None

 

 

*Denotes those persons acting in concert with Science Group plc, the party to the offer making the disclosure

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

31 October 2022

Contact name:

Sarah Cole

 

Group Legal Counsel & Company Secretary

 

Telephone number:

01223 875 200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEFLFFDIILLVIF
Date   Source Headline
5th Apr 201212:33 pmRNSHolding(s) in Company
5th Apr 201212:31 pmRNSHolding(s) in Company
30th Mar 201211:04 amRNSResult of EGM
15th Mar 20127:00 amRNSAcquisition and Placing
12th Mar 20127:00 amRNSTechnology Update
13th Jan 20129:34 amRNSHolding(s) in Company
4th Jan 20127:00 amRNSNew Technology Centre and Website
28th Nov 20119:47 amRNSHolding(s) in Company
22nd Nov 201111:49 amRNSHolding(s) in Company
17th Oct 20117:00 amRNSDirectorate Change
10th Oct 20113:53 pmRNSHolding(s) in Company
10th Oct 20113:46 pmRNSHolding(s) in Company
4th Oct 20117:00 amRNSBusiness Update
11th Aug 20117:00 amRNSInterim Results
11th Jul 20117:00 amRNSNotice of Results
28th Jun 20112:26 pmRNSHolding(s) in Company
6th Jun 20117:00 amRNSAppointment of Managing Director
19th May 201112:20 pmRNSAGM Update
19th May 201111:23 amRNSBusiness Update
17th May 20117:00 amRNSTechnology Partnership signed with Saudi Aramco
18th Apr 20117:00 amRNSDirector/PDMR Shareholding
4th Apr 201110:32 amRNSDirector/PDMR Shareholding
31st Mar 20117:00 amRNSDirector/PDMR Shareholding
29th Mar 20117:00 amRNSPreliminary Results
28th Mar 20117:00 amRNSMoU signed with new global industrial partner
28th Feb 20117:00 amRNSEuropean DGC Feasibility Study
10th Feb 20119:54 amRNSNorth America DGC Development Project Update
8th Feb 20117:00 amRNSAppointment of Non Executive Director
1st Feb 20117:00 amRNSPre-close Trading Statement
12th Jan 20117:00 amRNSDGC Update
17th Dec 201011:58 amRNSENI DGC Update
13th Dec 20104:53 pmRNSHolding(s) in Company
13th Dec 20103:03 pmRNSHolding(s) in Company
13th Dec 20103:00 pmRNSHolding(s) in Company
13th Dec 20102:56 pmRNSHolding(s) in Company
13th Dec 201011:39 amRNSHolding(s) in Company
7th Dec 201010:47 amRNSDirector/PDMR Shareholding
6th Dec 201012:41 pmRNSResults of General Meeting
25th Nov 20109:22 amRNSOperational Update
12th Nov 20105:12 pmRNSNotice of posting of prospectus
12th Nov 20107:00 amRNSPlacing and Open Offer
5th Nov 20102:45 pmRNSPress Speculation
25th Aug 20107:00 amRNSNew Development Agreement
12th Aug 20107:00 amRNSInterim Results
6th Aug 20107:00 amRNSNotification of Results and Change of Advisor
5th Jul 20107:00 amRNSAppointment of Chairman
30th Jun 20108:16 amRNSAnnual Financial Report
24th Jun 20101:12 pmRNSAGM Statement
4th May 20107:00 amRNSDirectors' Dealings
29th Apr 201011:19 amRNSDirectors Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.